Molecular Landscape of Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency in India

Key Points

• Congenital adrenal hyperplasia shows various genetic mutations influencing treatment strategies.
• Key evidence indicates diverse molecular profiles affecting 21-hydroxylase enzyme function in patients.
• This analysis utilizes genetic sequencing to identify biomarkers associated with steroid 21-hydroxylase deficiency.
• These findings suggest deeper genetic investigations are needed for personalized therapies in congenital adrenal hyperplasia.